EPHX2 and ischemic stroke: Deletion of sEH and inhibition of C-EH have similar consequences under multiple pathophysiological conditions, including insulin resistance [121], renal disease [122], psychiatric disorders [123], traumatic brain injury [124], atherosclerosis [125], ischemic stroke [126,127,128], hepatic steatosis [129], inflammatory bowel disease [130], and tissue/organ regeneration [131].